Targeting a $10 Billion Drug Resistance Market
https://finviz.com/news/368471/kairos-pharma-reports-breakthrough-interim-safety-data-in-phase-1-trial-of-env-105-in-egfr-mutated-lung-cancer-patients-targeting-a-10-billion-drug-resistance-market
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.